Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| BNAI | Brand Engagement Network | $6.03 | $2.42 | 66.90% | 27.8M | $16M | $1.18$10.50 |
| AZI | Autozi Internet Technology (Global) | $4.06 | $1.04 | 34.44% | 22.5M | $309M | $1.33$69.00 |
| LFS | Leifras | $3.22 | $0.75 | 30.17% | 664.7K | $65M | $1.58$12.49 |
| ROMA | Roma Green Finance | $2.15 | $0.40 | 22.86% | 72.8K | $104M | $0.58$4.66 |
| BMNG | Themes ETF Trust - Leverage Shares 2x Long Bmnr Daily ETF | $4.68 | $0.66 | 16.29% | 5.7M | - | $3.04$17.35 |
| BNR | Burning Rock Biotech | $27.68 | $3.61 | 15.00% | 18.4K | $217M | $2.18$27.68 |
| CERS | Cerus | $2.86 | $0.34 | 13.49% | 2M | $484M | $1.12$2.89 |
| MSTP | GraniteShares ETF Trust - GraniteShares 2x Long Mstr Daily ETF | $3.93 | $0.45 | 12.83% | 513.3K | - | $2.69$32.23 |
| DRTS | Alpha Tau Medical | $7.40 | $0.84 | 12.80% | 14.4K | $559M | $2.30$7.51 |
| MSTX | Tidal Trust II - Defiance Daily Target 2x Long Mstr ETF | $5.47 | $0.62 | 12.78% | 31.7M | - | $3.73$64.40 |
Related Articles
Featured Article
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy
James Brumley|Nov 5, 2025
The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?
Prosper Junior Bakiny|Oct 29, 2025
This stock has caught fire after some recent events, but how long will that last?
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?
Cory Renauer|Oct 26, 2025
The clinical-stage biotech is working on a new type of weight management drug.
Advertisement
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock
Adam Spatacco|Oct 12, 2024
BioAge Labs is the latest pharmaceutical company looking to make waves in the weight loss realm.
3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October
Alex Carchidi|Oct 5, 2024
There's a chance that its lead candidate could become one of the top drugs ever.
This IPO Biotech Stock Could Be the Next Eli Lilly
Alex Carchidi|Oct 3, 2024
BioAge has its eyes on a handful of truly gargantuan markets.
Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It?
Alex Carchidi|Jul 9, 2023
Its new focus on profitability might complicate its chances of growth.
2 Meme Stocks That Are Down More Than 80% From Their 52-Week Highs
David Jagielski, CPA|Apr 27, 2022
Are these stocks too cheap to pass up right now?
Clover Health Blows Past Expectations. Time to Buy?
Cory Renauer|Feb 24, 2022
An earnings beat and an improved outlook make this digital healthcare stock hard to ignore.
Bakkt Is Surging. Is the Stock Ready to Explode After Earnings?
Bram Berkowitz|Feb 14, 2022
The stock is up more than 60% over the past week. Is more upside ahead?
